An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Several professionals stated the popularity for retatrutide could be connected to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Response and Material Removal
Based on TikTok, the platform has taken down problematic content and prohibited related keywords and query recommendations. The company stated it was committed to keeping the platform secure and investing in strengthening compliance measures.
Digital Trading Operations
Research also discovered groups with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of members, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.
After moments of joining one community, a vendor shared contact information, where most purchases take place. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.
Item Details and Costs
Within these groups, messages show black plastic packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has previously seen patients harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.
